Systemic use of calcium channel blockers associated with less increase in central retinal thickness after uncomplicated cataract surgery.

Systemic vasoactive medication may be protective against CRT change induced by cataract surgery in eyes at risk of PCME such as those with postoperative steroid monotherapy.